Context Pituitary adenomas are relatively common tumours with diverse clinical features.
Epidemiological data are important to help quantify health burden. Objective To provide in …

Giant pituitary adenomas are a subgroup of pituitary adenomas defined by a diameter
greater than 4 cm, and they account for 5–14% of adenomas in surgical series. Because of …

The aim of the study was to evaluate the clinical features and long-term therapeutic outcome
of giant prolactinoma (gPRLoma) in men and to compare them with those of a group of male …

Lactotroph adenomas, also called prolactinomas and prolactin-secreting adenomas,
constitute nearly 80% of functioning pituitary tumors and about 30–50% of all adenomas in …

The general recommendation for pituitary adenoma patients is to withdraw medical therapy
as soon as pregnancy is diagnosed. However, in cases of macroadenomas, this decision …

Objective To evaluate the long-term outcomes and safety of endoscopic transsphenoidal
surgery (ETS) in recurrent and residual pituitary adenomas (rrPAs), as well as the predictors …

The aim of this study is to compare the efficacy of bromocriptine (BRC) versus cabergoline
(CAB) in patients with giant prolactinomas. We searched MEDLINE, EMBASE, CENTRAL …

We present a series of nonectopic pituitary adenomas presenting as polypoid sinonasal or
nasopharyngeal masses. Thirteen cases diagnosed by biopsies from the nasal cavity …

Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …

The management of aggressive pituitary adenomas represents a special clinical challenge,
and usually involves a combination of surgery, radiotherapy and pharmacological agents to …